Overview
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (19 papers)
-
Meilensteine in der Entwicklung der modernen Therapie des Morbus Parkinson
-
R-(—)-Deprenyl und Parkinsonismus
-
Ursachen des Morbus Parkinson: Pharmakologie und Biochemie von R-(—)-Deprenyl
-
Behandlung des Morbus Parkinson — Frühstadium
-
Behandlung des Morbus Parkinson — Spätstadium
Editors and Affiliations
Bibliographic Information
Book Title: Morbus Parkinson Selegilin (R-(—)-Deprenyl); Movergan®
Book Subtitle: Ein neues Therapiekonzept
Editors: Peter Riederer, Horst Przuntek
DOI: https://doi.org/10.1007/978-3-7091-2287-7
Publisher: Springer Vienna
-
eBook Packages: Springer Book Archive
Copyright Information: Springer-Verlag Wien 1988
Softcover ISBN: 978-3-211-82032-2Published: 09 February 1988
eBook ISBN: 978-3-7091-2287-7Published: 22 November 2013
Edition Number: 1
Number of Pages: X, 210
Number of Illustrations: 3 b/w illustrations
Topics: Pharmacology/Toxicology, Neurology, Psychiatry, Neurosciences, Biochemistry, general, Pharmacy
Industry Sectors: Biotechnology, Chemical Manufacturing, Consumer Packaged Goods, Health & Hospitals, Pharma